Dr. Robert Carroll Frere, MD

Dr. Frere practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.

Dr. Frere's NPI, 1669567095, was assigned on October 3, 2006. Dr. Frere graduated from Ohio State College of Medicine in 1984. Dr. Frere's North Carolina license number on file is 200000423.

Dr. Frere's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Dr. Frere's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. Dr. Frere is also affiliated with ECU Health Chowan Hospital. The medical group on file is ECU Health. Dmand AI also links Dr. Frere to 2 more hospitals, 4 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frere practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Frere's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Frere is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Frere's licenses on file in 3 states: North Carolina, Missouri and Minnesota.

Dmand AI lists alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, head injury, lower back pain and migraine and chronic headache among the conditions Dr. Frere treats.

CMS data shows 784 Medicare services from Dr. Frere across 11 procedure codes in 2024, for 401 Medicare patients. Medicare paid $54,821 for them.

CMS counts 401 Medicare patients who saw Dr. Frere in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frere's median patient age at 70, with 66% women.

In 2024, Dr. Frere wrote 3,475 Medicare Part D claims for 496 patients. 87% of them were for generic drugs. CMS names the drug for 3,113 of them, across 70 drugs with 11 or more claims each, at $2,695,297 in total drug cost. In 2023, CMS named 2,736 claims across 75 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Frere for performance year 2024, reported through an alternative payment model (APM). Dr. Frere accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frere as offering telehealth.

Dmand AI links 3 papers to Dr. Frere in 2021. The most frequent topics are Cerebral Cortex. Dr. Frere's most frequent co-authors are Shehabaldin Alqalyoobi, MD and Afua Quantson Kunadu, MD.

CMS Open Payments shows 514 general payments to Dr. Frere from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. Biogen, Inc. paid the most, $61,720.

Dmand AI lists 2 awards for Dr. Frere, most recently President in 2020.

Dr. Frere graduated from Ohio State College of Medicine in 1984.

Dr. Frere is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.